Rabies

A new single-shot rabies vaccine is showing promising results following a Phase 1 human clinical trial. Further clinical trials are now underway in the hopes the vaccine could help cut down the thousands of deaths every year from this viral disease.

New research has found that tobacco plants can be genetically modified to produce antibodies against the rabies virus.